delete The Prescription Only Medicines (Human Use) Amendment Order 2008
Amendment Order 2008 modifying the Prescription Only Medicines (Human Use) Order 1997. Key changes: (1) adds nurse and pharmacist independent prescribers as appropriate practitioners, (2) creates pharmacy-only classification for pseudoephedrine/ephedrine products with quantity limits (720mg pseudoephedrine, 180mg ephedrine max per transaction) and prohibitions on co-supply of both substances, (3) removes article 3A (nurse independent prescriber prescribing/administration rules), (4) modifies supplementary prescriber rules, (5) removes nurse independent prescriber references from hospital and exemption provisions, (6) omits Schedule 3A (controlled drugs for nurse independent prescribers).
This regulation implements pseudoephedrine/ephedrine scheduling restrictions that function as a de facto prohibition regime for pharmacy-only medicines. The quantity caps (720mg/180mg) and cross-substance prohibition create arbitrary barriers that restrict consumer access to legitimate over-the-counter products without evidence of meaningful public health benefit. These limits simply redirect consumers to alternative products or informal channels rather than reducing misuse. Additionally, the expansion of nurse/pharmacist independent prescriber categories adds regulatory complexity and state-controlled access points where market competition could instead expand consumer choice. The regulations perpetuate a paternalistic model where bureaucrats rather than individuals determine appropriate medicine access.